Thu, November 2, 2023

Eliana Merle Maintained (ANAB) at Hold with Decreased Target to $21 on, Nov 2nd, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-21-on-nov-2nd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Eliana Merle of UBS, Maintained "AnaptysBio, Inc." (ANAB) at Hold with Decreased Target from $28 to $21 on, Nov 2nd, 2023.

Eliana has made no other calls on ANAB in the last 4 months.



There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, all agrees with Eliana's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Nierengarten of "Wedbush" Maintained at Hold with Decreased Target to $26 on, Tuesday, August 8th, 2023